Effect of sertraline on regional metabolic rate in patients with affective disorder

Biological Psychiatry

Volumn 41, Issue 1, 1997, Pages 15-22

  Buchsbaum, Monte S ^a   Joseph, Wu ^b   Siegel, Benjamin V ^b   Hackett, Elizabeth ^b   Trenary, Mignon ^b   Abel, Lennert ^b   Reynolds, Chandra ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

18F deoxyglucose; cerebral metabolism; cingulate gyrus; glucose; positron emission tomography; serotonin

Indexed keywords

GLUCOSE; SERTRALINE;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

1-NAPHTHYLAMINE; ADULT; ANTIDEPRESSIVE AGENTS; BLOOD GLUCOSE; BRAIN MAPPING; CEREBRAL CORTEX; DEOXYGLUCOSE; DEPRESSIVE DISORDER; DOMINANCE, CEREBRAL; ENERGY METABOLISM; FEMALE; FLUORODEOXYGLUCOSE F18; GYRUS CINGULI; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PERSONALITY INVENTORY; SERTRALINE; THALAMUS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0343145706     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(96)00097-2     Document Type: Article

References (53)

1. Ågren H, Reibring L (1994): PET studies of presynaptic monoamine metabolism in depressed patients and healthy volunteers. Pharmacopsychiatry 27:2-6.
2. 11C]5-hydroxytryptophan in major depression: A positron emission tomography study on patients and healthy volunteers. Acta Psychiatr Scand 83:449-455.
3. American Psychiatric Association (1987): Diagnostic and Statistical Manual of Mental Disorders, 3rd ed rev. Washington, DC: American Psychiatric Press.
4. 2 binding sites in the frontal cortex of suicide victims and control subjects. Am J Psychiatry 146:730-736.
5. Baxter LR, Phelps ME, Mazziotta JC, et al (1985): Cerebral metabolic rates for glucose in mood disorders (studies with positron emission tomography and fluorodeoxyglucose F-18). Arch Gen Psychiatry 42:441-447.
6. Baxter LR, Jeffrey MS, Phelps ME, et al (1989): Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 46:243-250.
7. Bench CJ, Fristen KJ, Brown RG, Scott LC, Frackowiak RSJ, Dolan RJ (1992): The anatomy of melancholia - Focal abnormalities of cerebral blood flow in major depression. Psychol Med 22:607-615.
8. Biver F, Goldman S, Delvenne V, et al (1994): Frontal and parietal metabolic disturbances in unipolar depression. Biol Psychiatry 36:381-388.
9. Borst JGG, Leung SWS, MacFabe DF (1987): Electrical activity of the cingulate cortex: II. Cholinergic modulation. Brain Res 407:81-93.
10. Buchsbaum MS (1990): The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. Schizophr Bull 16:377-387.
11. Buchsbaum MS, DeLisi LE, Holcomb HH, et al (1984): Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. Arch Gen Psychiatry 41:1159-1166.
12. Buchsbaum MS, Tang SW, Wu JC, et al (1986): Effects of amoxapine and imipramine on cerebral glucose metabolism assessed by positron emission tomography. J Clin Psychiatry 4:14-17.
13. Buchsbaum MS, Wu JC, Haier RJ, et al (1987): Positron emission tomography assessment of effects of benzodiazepines on regional glucose metabolic rate in patients with anxiety disorder. Life Sci 40:2393-2400.
14. Buchsbaum MS, Gillin JC, Wu J, et al (1989): Regional cerebral glucose metabolic rate in human sleep assessed by positron emission tomography. Life Sci 45:1349-1356.
15. Buchsbaum MS, Haier RJ, Potkin SG, et al (1992): Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Arch Gen Psychiatry 49:1.
16. Cohen RM, Semple WE, Gross M, et al (1989): Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia. Neuropsychopharmacology 2:241-254.
17. Cohen RM, Gross M, Nordahl TE, Semple WE, Oren DA, Rosenthal N (1992): Preliminary data on the metabolic brain pattern of patients with winter seasonal affective disorder. Arch Gen Psychiatry 49:545-552.
18. Crow TJ, Cross AJ, Cooper SJ, et al (1984): Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression and suicides. Neuropharmacology 23:1561-1569.
19. Devous MD, Gullion CM, Grannemann BD, Trivedi MH, Rush AJ (1993): Regional cerebral blood flow alterations in unipolar depression. Psychiatry Res Neuroimaging 50:223-256.
20. D'Haenen H, Bossuyt A, Mertens M, Bossuyt-Piron C, Gijsermans M, Kaufman L (1992): SPECT imaging of serotonin-2 receptors in depression. Psychiatry Res Neuroimaging 45: 227-237.
21. Dixon WJ (1981): BMDP Biomedical Computer Programs. Berkeley, CA: University of California Press.
22. Doogan DP, Caillard V (1988): Sertraline: a new antidepressant. J Clin Psychiatry 49:46-51.
23. Doogan DP, Caillard V (1992): Sertraline in the prevention of depression. Br J Psychiatry 160:217-222.
24. Drevets WC, Videen TO, Price JL, Preskorn SH, Carmichael ST, Raichle ME (1992): A functional anatomical study of unipolar depression. J Neurosci 12:3628-3641.
25. Ebert D, Feistel H, Barocka A (1991): Effects of sleep deprivation in the limbic system and the frontal lobes: A study with Tc-99m-HMPAO SPECT. Psychiatry Res Neuroimaging 40: 247-251.
26. Ebert D, Feistel H, Barocka A, Kaschka W (1994): Increased limbic blood flow and total sleep deprivation in major depression with melancholia. Psychiatry Res Neuroimaging 55:101-109.
27. Gillin JC, Sitaram N, Wehr T, et al (1984): Sleep and affective illness. In Post RM, Ballenger JC (eds), Neurobiology of Mood Disorders. Baltimore: Williams & Wilkins Co., pp. 157-189.
28. Hamilton M (1960): A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
29. 3H]imipramine localization and relationship to serotonin transporter. J Pharmacol Exp Ther 252: 410-418.
30. Hurwitz TA, Clark C, Murphy E, Klonoff H, Martin WRW, Pate BD (1990): Regional cerebral glucose metabolism in major depressive disorder. Can J Psychiatry 35:684-688.
31. Itil TM, Itil KZ, Mukherjee S, et al (1988): A dose-finding study with sertraline, a new 5-HT reuptake blocking antidepressant using quantitative pharmaco-EEG and dynamic brain mapping. Presented at the XVth C.I.N.P. Congress, Munich, Germany.
32. Kapur S, Meyer J, Wilson AA, Houle S, Brown G (1994): Modulation of cortical neuronal activity by a serotonergic agent: A PET study in humans. Brain Res 646:292-294.
33. Koe BK, Weissman A, Welch WM, et al (1983): Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1 -naphthylamine, a new uptake inhibitor with selectivity for serotonin. J Pharmacol Exp Ther 226:686-700.
34. Leake A, Fairbairn AF, McKeith IG, et al (1991): Studies on the serotonin uptake binding site in major depressive disorder and control post-mortem brain: Neurochemical and clinical correlates. Psychiatry Res 39:155-165.
35. Martinot J-L, Hardy P, Feline A, et al (1990): Left prefrontal glucose hypometabolism in the depressed state: A confirmation. Am J Psychiatry 147:1313-1317.
36. 1A binding sites in frontal cortex of suicide victims. J Neural Transm Gen Sect 85:181-194.
37. Matsui T, Hirano A (1978): An Atlas of the Human Brain for Computerized Tomography. Tokyo: Igaku-Shoin.
38. 2 serotonin receptors after stroke: Lateralized changes and relationship to depression. Am J Psychiatry 145:937-943.
39. Meltzer HY (1990): Role of serotonin in depression. Ann NY Acad Sci 600:486-500.
40. Nuechterlein KH, Parasuraman R, Jiang Q (1983): Visual sustained attention: Image degradation produces rapid decrement over time. Science 220:327-329.
41. Pazos A, Probst A, Palacios JM (1987a): Serotonin receptors in the human brain: III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience 21:97-122.
42. Pazos A, Probst A, Palacios JM (1987b): Serotonin receptors in the human brain: IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience 21:123-139.
43. Price LH, Charney DS, Delgado PL, et al (1991): Serotonin function and depression: Neuroendocrine and mood responses to intravenous L-tryptophan in depressed patients and healthy comparison subjects. Am J Psychiatry 148:1518-1525.
44. 11C]5-hydroxytryptophan in human brain studied by positron emission tomography. Psychiatry Res Neuroimaging 45:215-225.
45. Reimherr FW, Byerley WF, Ward MF, et al (1988): Sertraline, a selective inhibitor of serotonin uptake, for the treatment of outpatients with major depressive disorder. Psychopharmacol Bull 24:200-205.
46. Reimherr FW, Chouinard G, Cohn CK (1990): Antidepressant efficacy of sertraline: A double-blind, placebo-and amitryptyline-controlled, multicenter comparison study in outpatients with major depression. J Clin Psychiatry 51:18-27.
47. Saper CB (1984): Organization of cerebral cortical afferent systems in the rat: II. Magnocellular basal nucleus. J Comp Neurol 222:313-342.
48. Siegel BV, Asarnow R, Tanguay P, et al (1992): Regional cerebral glucose metabolism and attention in adults with a history of childhood autism. J Neuropsychiatry Clin Neurosci 4:406-414.
49. Sitaram N, Moore AM, Gillin JC (1979): Scopolamine-induced muscarinic supersensitivity in normal man: Changes in sleep. Psychiatry Res 1:9-16.
50. Steinbusch HWM (1984): Serotonin-immunoreactive neurons and their projections in the CNS. In Björklund A, Hökfelt T (eds), Handbook of Chemical Neuroanatomy. Vol. 3: Classical Transmitters and Transmitter Receptors in the CNS, Part II. Amsterdam: Elsevier, pp 68-125.
51. 1Dβ. Proc Natl Acad Sci 89:3630-3634.
52. 11C]-methyl)-2-Br-LSD. Synapse 1:393-398.
53. Wu JC, Gillin JC, Buchsbaum MS, Hershey T, Johnson JC, Bunney WE (1992): Effect of sleep deprivation on brain metabolism of depressed patients. Am J Psychiatry 149:538-543.